The Molecular Mechanism of "ecstasy" [3,4-methylenedioxy-methamphetamine (MDMA)]: Serotonin Transporters Are Targets for MDMA-induced Serotonin Release

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 1992 Mar 1

PMID 1347426

Citations 132

Authors

G Rudnick

S C Wall

Affiliations

Soon will be listed here.

Abstract

MDMA ("ecstasy") has been widely reported as a drug of abuse and as a neurotoxin. This report describes the mechanism of MDMA action at serotonin transporters from plasma membranes and secretory vesicles. MDMA stimulates serotonin efflux from both types of membrane vesicle. In plasma membrane vesicles isolated from human platelets, MDMA inhibits serotonin transport and [3H]imipramine binding by direct interaction with the Na(+)-dependent serotonin transporter. MDMA stimulates radiolabel efflux from plasma membrane vesicles preloaded with [3H]serotonin in a stereo-specific, Na(+)-dependent, and imipramine-sensitive manner characteristic of transporter-mediated exchange. In membrane vesicles isolated from bovine adrenal chromaffin granules, which contain the vesicular biogenic amine transporter, MDMA inhibits ATP-dependent [3H]serotonin accumulation and stimulates efflux of previously accumulated [3H]serotonin. Stimulation of vesicular [3H]serotonin efflux is due to dissipation of the transmembrane pH difference generated by ATP hydrolysis and to direct interaction with the vesicular amine transporter.

Citing Articles

Balancing Therapeutic Efficacy and Safety of MDMA and Novel MDXX Analogues as Novel Treatments for Autism Spectrum Disorder.

Kaur H, Karabulut S, Gauld J, Fagot S, Holloway K, Shaw H Psychedelic Med (New Rochelle). 2025; 1(3):166-185.

PMID: 40046567 PMC: 11661495. DOI: 10.1089/psymed.2023.0023.

Fluorescent non-canonical amino acid provides insight into the human serotonin transporter.

Nygaard A, Zachariassen L, Larsen K, Kristensen A, Loland C Nat Commun. 2024; 15(1):9267.

PMID: 39463388 PMC: 11514162. DOI: 10.1038/s41467-024-53584-9.

MDMA for treatment of PTSD and neurorehabilitation in military populations.

Dunn W, Bershad A, Krantz D, Vermetten E NeuroRehabilitation. 2024; 55(3):357-368.

PMID: 39331116 PMC: 11612990. DOI: 10.3233/NRE-230270.

Epigenetic mechanisms of rapid-acting antidepressants.

Inserra A, Campanale A, Rezai T, Romualdi P, Rubino T Transl Psychiatry. 2024; 14(1):359.

PMID: 39231927 PMC: 11375021. DOI: 10.1038/s41398-024-03055-y.

Bioisosteric analogs of MDMA: Improving the pharmacological profile?.

Alberto-Silva A, Hemmer S, Bock H, da Silva L, Scott K, Kastner N J Neurochem. 2024; 168(9):2022-2042.

PMID: 38898705 PMC: 11449655. DOI: 10.1111/jnc.16149.

References

OHearn E, Battaglia G, DE SOUZA E, Kuhar M, Molliver M . Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: immunocytochemical evidence for neurotoxicity. J Neurosci. 1988; 8(8):2788-803. PMC: 6569396. View

LOWRY O, ROSEBROUGH N, FARR A, RANDALL R . Protein measurement with the Folin phenol reagent. J Biol Chem. 1951; 193(1):265-75. View

Nichols D, Lloyd D, Hoffman A, Nichols M, YIM G . Effects of certain hallucinogenic amphetamine analogues on the release of [3H]serotonin from rat brain synaptosomes. J Med Chem. 1982; 25(5):530-5. DOI: 10.1021/jm00347a010. View

Rudnick G, Fishkes H, Nelson P, Schuldiner S . Evidence for two distinct serotonin transport systems in platelets. J Biol Chem. 1980; 255(8):3638-41. View

Mota I, BERALDO W, FERRI A, JUNQUEIRA L . Intracellular distribution of histamine. Nature. 1954; 174(4432):698. DOI: 10.1038/174698a0. View

Fuller R, HINES C, Mills J . LOWERING OF BRAIN SEROTONIN LEVEL BY CHLORAMPHETAMINES. Biochem Pharmacol. 1965; 14:483-8. DOI: 10.1016/0006-2952(65)90221-2. View

Schmidt C, Levin J, Lovenberg W . In vitro and in vivo neurochemical effects of methylenedioxymethamphetamine on striatal monoaminergic systems in the rat brain. Biochem Pharmacol. 1987; 36(5):747-55. DOI: 10.1016/0006-2952(87)90729-5. View

Njus D, Kelley P, Harnadek G . Bioenergetics of secretory vesicles. Biochim Biophys Acta. 1986; 853(3-4):237-65. DOI: 10.1016/0304-4173(87)90003-6. View

Marcusson J, Backstrom I, Ross S . Single-site model of the neuronal 5-hydroxytryptamine uptake and imipramine-binding site. Mol Pharmacol. 1986; 30(2):121-8. View

10.

Ricaurte G, Bryan G, Strauss L, Seiden L, Schuster C . Hallucinogenic amphetamine selectively destroys brain serotonin nerve terminals. Science. 1985; 229(4717):986-8. DOI: 10.1126/science.4023719. View

11.

BARTHOLINI G, Pletscher A . Two types of 5-hydroxytryptamine release from isolated blood platelets. Experientia. 1964; 20(7):376-8. DOI: 10.1007/BF02147970. View

12.

Barber A, Jamieson G . Isolation and characterization of plasma membranes from human blood platelets. J Biol Chem. 1970; 245(23):6357-65. View

13.

Knoth J, Zallakian M, Njus D . Stoichiometry of H+-linked dopamine transport in chromaffin granule ghosts. Biochemistry. 1981; 20(23):6625-9. DOI: 10.1021/bi00526a016. View

14.

Knoth J, Peabody J, Huettl P, Njus D . Kinetics of tyramine transport and permeation across chromaffin-vesicle membranes. Biochemistry. 1984; 23(9):2011-6. DOI: 10.1021/bi00304a020. View

15.

Talvenheimo J, Fishkes H, Nelson P, Rudnick G . The serotonin transporter-imipramine "receptor". J Biol Chem. 1983; 258(10):6115-9. View

16.

Fishkes H, Rudnick G . Bioenergetics of serotonin transport by membrane vesicles derived from platelet dense granules. J Biol Chem. 1982; 257(10):5671-7. View

17.

Schuldiner S, Fishkes H, Kanner B . Role of a transmembrane pH gradient in epinephrine transport by chromaffin granule membrane vesicles. Proc Natl Acad Sci U S A. 1978; 75(8):3713-6. PMC: 392856. DOI: 10.1073/pnas.75.8.3713. View

18.

Maron R, Kanner B, Schuldiner S . The role of a transmembrane pH gradient in 5-hydroxy tryptamine uptake by synaptic vesicles from rat brain. FEBS Lett. 1979; 98(2):237-40. DOI: 10.1016/0014-5793(79)80190-8. View

19.

Talvenheimo J, Nelson P, Rudnick G . Mechanism of imipramine inhibition of platelet 5-hydroxytryptamine transport. J Biol Chem. 1979; 254(11):4631-5. View

20.

Nelson P, Rudnick G . Coupling between platelet 5-hydroxytryptamine and potassium transport. J Biol Chem. 1979; 254(20):10084-9. View